兩連板萬方發展(000638.SZ):疫苗產品產業化存在不確定性
格隆匯 9 月 15日丨萬方發展(000638.SZ)公佈,公司股票於2020年9月11日、9月14日、9月15日連續三個交易日收盤價格漲幅偏離值累計達到20%,根據《深圳證券交易所股票交易規則》的相關規定,屬於股票交易異常波動。
2020年9月12日,公司在指定信息披露媒體上披露了《關於設立控股子公司的公告》。截至目前,該控股子公司尚未完成工商設立登記手續,待工商登記完成後公司將按照規定及時履行信息披露義務。
此次對外投資設立的控股子公司屬於生物製品行業,未來主要研發疫苗產品。由於疫苗產品的研發週期長、技術難度大、研發風險高等特點,研究成果能否順利實現產業化存在一定的不確定性,且公司面臨市場競爭不斷加劇和一定的管理風險,敬請廣大投資者注意投資風險。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.